- Home
- MPU vs NSPR Comparison
MPU vs NSPR Comparison
Compare MPU & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPU
- NSPR
- Stock Information
- Founded
- MPU 1989
- NSPR 2005
- Country
- MPU Singapore
- NSPR Israel
- Employees
- MPU N/A
- NSPR N/A
- Industry
- MPU Transportation Services
- NSPR Medical/Dental Instruments
- Sector
- MPU Consumer Discretionary
- NSPR Health Care
- Exchange
- MPU Nasdaq
- NSPR Nasdaq
- Market Cap
- MPU 77.9M
- NSPR 63.0M
- IPO Year
- MPU 1998
- NSPR N/A
- Fundamental
- Price
- MPU $1.63
- NSPR $2.53
- Analyst Decision
- MPU
- NSPR Buy
- Analyst Count
- MPU 0
- NSPR 1
- Target Price
- MPU N/A
- NSPR $4.50
- AVG Volume (30 Days)
- MPU 114.6K
- NSPR 36.3K
- Earning Date
- MPU 11-12-2024
- NSPR 11-12-2024
- Dividend Yield
- MPU N/A
- NSPR N/A
- EPS Growth
- MPU N/A
- NSPR N/A
- EPS
- MPU N/A
- NSPR N/A
- Revenue
- MPU $25,996,600.00
- NSPR $6,821,000.00
- Revenue This Year
- MPU N/A
- NSPR $12.28
- Revenue Next Year
- MPU N/A
- NSPR $53.44
- P/E Ratio
- MPU N/A
- NSPR N/A
- Revenue Growth
- MPU 419200.00
- NSPR 24.70
- 52 Week Low
- MPU $0.77
- NSPR $1.81
- 52 Week High
- MPU $4.48
- NSPR $3.42
- Technical
- Relative Strength Index (RSI)
- MPU 57.44
- NSPR 52.32
- Support Level
- MPU $1.47
- NSPR $2.07
- Resistance Level
- MPU $1.84
- NSPR $3.05
- Average True Range (ATR)
- MPU 0.17
- NSPR 0.23
- MACD
- MPU 0.01
- NSPR 0.02
- Stochastic Oscillator
- MPU 57.14
- NSPR 46.94
About MPU Mega Matrix Corp.
Mega Matrix Corp is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.